Valuation: Enovis Corporation

Market Cap 1.48B 1.3B 1.2B 1.11B 2.1B 142B 2.14B 14.35B 5.63B 69.67B 5.57B 5.44B 241B P/E 2026 *
212x
P/E 2027 * 26.7x
Enterprise Value 2.68B 2.35B 2.18B 2B 3.79B 256B 3.86B 25.94B 10.18B 126B 10.06B 9.84B 435B EV / Sales 2026 *
1.14x
EV / Sales 2027 * 1.03x
Free-Float
98.38%
Yield 2026 *
-
Yield 2027 * -
1 day+1.94%
1 week+1.35%
Current month+26.81%
1 month+25.12%
3 months+5.59%
6 months+6.45%
Current year-1.46%
1 week 23.32
Extreme 23.315
27.08
1 month 19.14
Extreme 19.14
27.08
Current year 19.14
Extreme 19.14
29.89
1 year 19.14
Extreme 19.14
34.28
3 years 19.14
Extreme 19.14
66.14
5 years 19.14
Extreme 19.14
164.01
10 years 19.14
Extreme 19.14
164.01
Manager TitleAgeSince
Chief Executive Officer 61 12/05/2025
Director of Finance/CFO 47 01/01/2023
Chief Tech/Sci/R&D Officer - 01/01/2026
Director TitleAgeSince
Director/Board Member 55 13/05/2008
Director/Board Member 67 21/09/2010
Chairman 64 21/05/2025
Date Insider Type Main position Quantity % Market Cap.
30/06Free

Director

846 0.0015%
15/06Buy

Chief Administrative Officer

1,000 0.0017%
11/06Free

Chief Administrative Officer

1,000 0.0017%
Change 5-day change 1-year change 3-year change Capi.($)
+1.94%+1.35%-17.87%-59.90% 1.48B
+0.51%+2.07%-15.33%+10.62% 126B
+1.27%+1.63%+3.17%-1.24% 12.9B
0.00%+2.70%+46.58%+113.18% 8.97B
-2.84%-5.15%-50.08%-72.78% 3.98B
+1.52%+0.15%+22.38%+47.77% 2.7B
-5.07%-12.37%-19.07%-27.93% 1.74B
-1.19%-5.02%-7.21%-24.81% 1.61B
-0.77%+3.86%-60.57%-84.12% 1.49B
Average -0.48%+2.48%-10.89%-11.02% 17.92B
Weighted average by Cap. +0.43%+1.19%-11.04%+11.64%

Financials

2026 *2027 *
Net sales 2.34B 2.06B 1.9B 1.75B 3.32B 224B 3.38B 22.7B 8.9B 110B 8.81B 8.61B 381B 2.47B 2.16B 2B 1.84B 3.49B 236B 3.55B 23.88B 9.37B 116B 9.26B 9.06B 400B
Net income 2.96M 2.6M 2.4M 2.21M 4.18M 283M 4.27M 28.66M 11.24M 139M 11.12M 10.87M 480M 54.22M 47.56M 44.05M 40.53M 76.66M 5.19B 78.15M 525M 206M 2.55B 204M 199M 8.8B
Net Debt 1.2B 1.05B 973M 895M 1.69B 115B 1.73B 11.59B 4.55B 56.28B 4.5B 4.4B 194B 1.07B 935M 866M 797M 1.51B 102B 1.54B 10.32B 4.05B 50.1B 4B 3.92B 173B
Logo Enovis Corporation
Enovis Corporation is a medical technology company. It is focused on developing clinically differentiated solutions by manufacturing and distributing high-quality medical devices with a range of products used for reconstructive surgery, rehabilitation, pain management and physical therapy. It operates through two segments: Prevention & Recovery and Reconstructive. The Prevention & Recovery segment provides orthopedic and recovery science solutions, including devices, software, and services across the patient care continuum from injury prevention to rehabilitation after surgery, injury, or from degenerative diseases. The Prevention & Recovery products are marketed under several brand names, such as DJO. The Reconstructive segment provides surgical implant solutions, offering a comprehensive suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and finger and surgical productivity tools. It also operates a Enovis Growth eXcellence business system (EGX).
Employees
7,802
Date Price Change Volume
14/07/26 USD 26.25 +1.94% 914,586
10/07/26 USD 25.75 +2.10% 768,242
09/07/26 USD 25.22 +6.73% 1,940,894
08/07/26 USD 23.63 -7.41% 1,213,833
07/07/26 USD 25.52 -1.47% 989,227
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
12
Last Close Price
25.75USD
Average target price
40.73USD
Spread / Average Target
+58.16%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. ENOV Stock